Efficacy of poly(ADP-ribose) polymerase inhibitor olaparib against head and neck cancer cells: Predictions of drug sensitivity based on PAR-p53-NF-κB interactions. (December 2016) - Kwon, M.; Cho, H.J.; Lee, Y.S.; Park, J.J.; Seo, J.H.